Search results for: 'detection of pollution carbonaceous particles biological sample'

The South Korean Advanced Malware Detection Solution market witnessed a steady YoY growth in 2018. Though cloud-based deployments are expected to grow at a much higher CAGR, on-premises deployments are expected to dominate the South Korean AMD solutions market until 2023. Cyberattacks are becoming more sophisticated. The latest attacks included...

07 Sep 2015  |  North America  |  Market Research

US Nucleic Acid Purification and Isolation Markets

Critical Sample Preparation Step Benefits from Downstream Applications

Infographics

×

The total market, as defined by this study, includes nucleic acid purification and isolation reagents (including kits and homebrew reagents) and nucleic acid purification and isolation instruments in the United States. The study period runs from 2011 to 2021, with 2014 as the base year and 2015–2021 as the forecast period. This research service off...

30 Apr 2020  |  Global  |  Market Research

Global Managed Detection and Response Market, Forecast to 2024

Attack Complexity will Drive Growth of MDR Services

Infographics

×

The managed detection and response (MDR) market generated $893.8 million in 2019; it is set to grow at a CAGR of 16.4% and reach $1,907.9 million by 2024. With the increasing number and complexity of threats, the internal management of information security has become increasingly laborious and costly. In this context, outsourcing should be vi...

The AMD solution market in Greater China experienced robust YoY growth of 30.4%, becoming the second largest AMD market in the Asia-Pacific region. On-premise AMD solution remained the key revenue generator as it was the preferred deployment option in Greater China. Local Chinese vendors, such as Huawei, DBAPPSecurity, and NSFOCUS, experienced trem...

The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...

From an extremely competitive and fast-growing field of more than 70 extended detection and response (XDR) participants globally with revenue greater than $1.0 million, Frost & Sullivan independently plotted 17 of the top companies in this Frost Radar™ analysis. In 2023, XDR is showing impressive revenue growth in the cybersecurity industry after...

Over the past decade, security incidents have increased in frequency and sophistication. A growing number of cyberattacks are sponsored by nation-states, while the attack surface continues to expand in a time of rapid digitalization. Organizations find it increasingly difficult to keep up to date with new developments in cybersecurity and to secure...

The rapid evolution of enterprise IT environments, driven by cloud adoption, connected devices, and hybrid infrastructure, has rendered legacy perimeter defenses inadequate. Network detection and response (NDR) has become a strategic imperative, providing continuous visibility across network traffic to identify advanced threats that evade endpoint...

24 Jul 2020  |  North America  |  Market Research

Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024

Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies

Infographics

×

Key Issues Addressed

With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, r...